Cat · Felis catus · typical adult weight 2.50–7.00 kg
Pasireotide is dosed at 0.03–0.1 mg/kg SC q12h or monthly (LAR) in cats, per Corroborated 2026-07-31: Scudder CJ et al. J Vet Intern Med 2015;29(4):1074-1080. doi:10.1111/jvim.12608 PMID:25945588 - cat, hypersomatotropism, pasireotide 0.03 mg/kg SC q12h (3-day study); monthly LAR 6-8 mg/kg SC (Gostelow R et al. J Vet Intern Med 2017;31(2):355-364. doi:10.1111/jvim.14662 PMID:28145031).. Pasireotide is used in cats for Acromegaly / pituitary-dependent Cushing's. Routes documented in cats: SC. A typical adult cat weighs 2.50–7.00 kg. ExoticRx lists 1 cited dose rule for Pasireotide in cats, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Signifor
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| SC | 0.03–0.1 mg/kg | q12h or monthly (LAR) | Investigational; long-term | Acromegaly / pituitary-dependent Cushing's | Weak | Corroborated 2026-07-31: Scudder CJ et al. J Vet Intern Med 2015;29(4):1074-1080. doi:10.1111/jvim.12608 PMID:25945588 - cat, hypersomatotropism, pasireotide 0.03 mg/kg SC q12h (3-day study); monthly LAR 6-8 mg/kg SC (Gostelow R et al. J Vet Intern Med 2017;31(2):355-364. doi:10.1111/jvim.14662 PMID:28145031). |
Need the exact dose for your patient?
These ranges are per kg. Enter your cat's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Somatostatin analogue with broad somatostatin receptor affinity (SST1,2,3,5) that suppresses ACTH secretion from corticotroph adenomas.
Hyperglycemia is very common. Monitor blood glucose. Investigational for pituitary-dependent hyperadrenocorticism in dogs.
Species-specific contraindications and adverse-reaction reports for cats may differ from canine / feline reference data — consult the primary citations listed with each rule.
Pasireotide dose range in cats, with cited source references: SC 0.03–0.1 mg/kg q12h or monthly (LAR). Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Pasireotide in cats: SC.
Cited course lengths for Pasireotide in cats include: Investigational; long-term. Duration depends on the indication — match it to the specific dose rule in the table above.
Pasireotide is indicated in cats for: Acromegaly / pituitary-dependent Cushing's.
These are general warnings for Pasireotide across species; consult the cat dosing table above for species-specific guidance. Hyperglycemia is very common. Monitor blood glucose. Investigational for pituitary-dependent hyperadrenocorticism in dogs.
Why a species-specific page? Pasireotide pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in cats — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.